EUVIMEDEUVIMED entdecken
Open Access

Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture

Daniel C Rabe iD, Adarsh Choudhury iD, Dasol Lee iD, Evelyn G Luciani iD, Uyen K Ho iD, Alex E Clark iD, Jeffrey E Glasgow iD, Sara Veiga, William A Michaud iD, Diane Capen iD, Elizabeth A Flynn, Nicola Hartmann iD und 14 weitere

Science Advances · 2025

DOI: 10.1126/sciadv.adh1167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Daniel C Rabe und 25 weiteren Autor:innen. Beteiligte Einrichtung: Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Angiotensin-Converting Enzyme 2, Saliva. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, NCI NIH HHS, NCEZID CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Measuring virus in biofluids is complicated by confounding biomolecules coisolated with viral nucleic acids. To address this, we developed an affinity-based microfluidic device for specific capture of intact severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Our approach used an engineered angiotensin-converting enzyme 2 to capture intact virus from plasma and other complex biofluids. Our device leverages a staggered herringbone pattern, nanoparticle surface coating, and processing conditions to achieve detection of as few as 3 viral copies per milliliter. We further validated our microfluidic assay on 103 plasma, 36 saliva, and 29 stool samples collected from unique patients with COVID-19, showing SARS-CoV-2 detection in 72% of plasma samples. Longitudinal monitoring in the plasma revealed our device’s capacity for ultrasensitive detection of active viral infections over time. Our technology can be adapted to target other viruses using relevant cell entry molecules for affinity capture. This versatility underscores the potential for widespread application in viral load monitoring and disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Angiotensin-Converting Enzyme 2SalivaHumansViral LoadLab-On-A-Chip DevicesFecesMicrofluidicsMicrofluidic Analytical Techniques

Substanzen

Angiotensin-Converting Enzyme 2ACE2 protein, human

Autor:innen und Institutionen

  • Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA.
  • Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Departments of Pathology and Medicine, School of Medicine, University of California, San Diego, La Jolla, CA, USA.
  • Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.

ORCID-Profile: Daniel C Rabe, Adarsh Choudhury, Dasol Lee, Evelyn G Luciani, Uyen K Ho, Alex E Clark, Jeffrey E Glasgow, William A Michaud, Diane Capen, Nicola Hartmann, Aaron F Garretson, Marcia B Goldberg, Douglas S Kwon, Xu Yu, Aaron F Carlin, Yves Theriault, James A Wells, Jochen K Lennerz, Peggy S Lai, Genevieve M Boland, Shannon L Stott

Förderung

  • NCATS NIH HHS
  • NCI NIH HHS
  • NCEZID CDC HHS
  • NIAID NIH HHS
  • NLM NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Rabe, D. C., Choudhury, A., Lee, D., Luciani, E. G., Ho, U. K., Clark, A. E., Glasgow, J. E., Veiga, S., Michaud, W. A., Capen, D., Flynn, E. A., Hartmann, N., Garretson, A. F., Muzikansky, A., Goldberg, M. B., Kwon, D. S., Yu, X., Carlin, A. F., Theriault, Y., …, & Stott, S. L. (2025). Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture. Science Advances. https://doi.org/10.1126/sciadv.adh1167

Vancouver

Rabe DC, Choudhury A, Lee D, Luciani EG, Ho UK, Clark AE, et al. Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture. Science Advances. 2025. doi:10.1126/sciadv.adh1167

BibTeX
@article{Rabe2025,
  author = {Rabe, Daniel C and Choudhury, Adarsh and Lee, Dasol and Luciani, Evelyn G and Ho, Uyen K and Clark, Alex E and Glasgow, Jeffrey E and Veiga, Sara and Michaud, William A and Capen, Diane and Flynn, Elizabeth A and Hartmann, Nicola and Garretson, Aaron F and Muzikansky, Alona and Goldberg, Marcia B and Kwon, Douglas S and Yu, Xu and Carlin, Aaron F and Theriault, Yves and Wells, James A and Lennerz, Jochen K and Lai, Peggy S and Rabi, Sayed Ali and Hoang, Anh N and Boland, Genevieve M and Stott, Shannon L},
  title = {Ultrasensitive detection of intact SARS-CoV-2 particles in complex biofluids using microfluidic affinity capture},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adh1167}
}
Kostenlos starten →